Most recent update: Tuesday, September 19, 2017 - 17:23

Bariatric News - Cookies & privacy policy

You are here


18/09/17 - Research
Dairy and diabetes risk
Scientists are looking at how differences in body composition may be a possible explanation for why consumption of some dairy products may be associated with a lower risk of developing type 2...
18/09/17 - Research
Reversing eye damage
Early eye damage caused by obesity, high blood pressure and diabetes can potentially be reversed by bariatric surgery, according to a study presented at this year's Annual Meeting of the European...
13/09/17 - Research
Healthy obesity
Clinicians are being warned not to ignore the increased cardiovascular health risks of those who are classed as either 'healthy obese' or deemed to be 'normal weight' but have metabolic abnormalities...
12/09/17 - Research
Revita DMR data
Fractyl Laboratories and clinical investigators for the Revita-1 clinical trial have report one-year data from the study showing sustained improvement in glycaemic parameters following a single...
13/09/17 - Research
Hypertension-related morbidities
Patients who have substantial weight loss after bariatric surgery reduce their risk of acute care use for hypertension-related disease decreased by 40%, according to research by investigators from...
19/09/17 - Industry
Stretta cases in Brazil
Mederi Therapeutics has announced that the first cases of Stretta Therapy, a non-surgical treatment for gastroesophageal reflux disease (GERD), have been performed in Brazil. Dr Manoel Galvao Neto...
18/09/17 - Research
Diabetes research
A body of research putting people with Type 2 diabetes on a low-calorie diet has confirmed the underlying causes of the condition and established that it is reversible. Professor Roy Taylor at...
18/09/17 - Research
Obesity and cancer
Obese women with large bellies may be at risk of developing a different subtype of breast cancer than those with widespread fat accumulation, according to a study published in The Oncologist. The...

Monthly archive